A new investigational cancer vaccine developed by Merck & Co. and Moderna is customized based on the genome of each patient's ...
A WuXi AppTec director examines strategies for improving oral PROTAC exposure, from food-effect studies and linker design to ...
AbbVie's MAVYRET became the first of those antivirals cleared for acute infection in June 2025, with a 96% cure rate in trial ...
Medable’s Pamela Tenaerts says “the CRA still needs to be there,” as she and Tufts’ Ken Getz explain how agents change ...
The FDA has approved ViiV Healthcare’s Tivicay PD (dolutegravir) for treating HIV-1 in pediatric patients weighing at least 2 ...
FDA has logged more than 1,700 adverse event reports involving compounded semaglutide and tirzepatide as regulators, ...
Drug Discovery and Development covers strategies and technologies related to pharmaceutical research and development and drug formulation.
The FDA has finalized new guidelines for meetings between the FDA and sponsors or applicants relating to the development and review of drugs or biological products under the Prescription Drug User Fee ...
Antibody-drug conjugates (ADCs) have emerged as one of the busiest and most crowded niches within oncology, given their potential to use an antibody to ferry a potent cytotoxic payload toward tumor ...
The 1990-founded scientific software firm Schrödinger recently announced a strategic collaboration and software agreement with Bristol Myers Squibb (BMS) built around Bunsen, Schrödinger’s newly ...
Earendil Labs and NewLimit round out the top three slots in the ranking below, which is limited to private biotechs that announced or disclosed financing between Jan. 1 and Aug. 12, 2026. Earendil ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results